Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.

Baldini, N., De Milito, A., Feron, O., Gillies, R.J., Michiels, C., Otto, A.M., et al. (2017). Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer. FRONTIERS IN PHARMACOLOGY, 8, 1-5 [10.3389/fphar.2017.00411].

Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer

Baldini, Nicola;Avnet, Sofia
2017

Abstract

Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.
2017
Baldini, N., De Milito, A., Feron, O., Gillies, R.J., Michiels, C., Otto, A.M., et al. (2017). Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer. FRONTIERS IN PHARMACOLOGY, 8, 1-5 [10.3389/fphar.2017.00411].
Baldini, Nicola; De Milito, Angelo; Feron, Olivier; Gillies, Robert J.; Michiels, Carine; Otto, Angela M.; Pastoreková, Silvia; Pedersen, Stine F.; Po...espandi
File in questo prodotto:
File Dimensione Formato  
Annual Meeting of the International Society of Cancer Metabolism (ISCaM).pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 188.99 kB
Formato Adobe PDF
188.99 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/624658
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 6
social impact